272 related articles for article (PubMed ID: 8135032)
21. History of calcium antagonists.
Fleckenstein A
Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
[TBL] [Abstract][Full Text] [Related]
22. Calcium entry blockers and cardiovacular failure.
Vanhoutte PM
Fed Proc; 1981 Dec; 40(14):2882-87. PubMed ID: 7308499
[TBL] [Abstract][Full Text] [Related]
23. Calcium channels in the heart.
Poole-Wilson PA
Postgrad Med J; 1991; 67 Suppl 3():S16-9. PubMed ID: 1661893
[TBL] [Abstract][Full Text] [Related]
24. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
Kocurek A; Piwowarska W
Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
[TBL] [Abstract][Full Text] [Related]
25. Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
Takahashi T; Takahashi K; Kishi-Tanikawa S; Tsuchida K; Araki H; Higuchi S
J Pharmacol Exp Ther; 1996 Sep; 278(3):1028-33. PubMed ID: 8819482
[TBL] [Abstract][Full Text] [Related]
26. [Conservative treatment concepts for stable angina pectoris in coronary heart disease].
Schoebel FC; Leschke M; Heintzen MP; Strauer BE
Med Klin (Munich); 1996 Jul; 91(7):458-65. PubMed ID: 8756115
[No Abstract] [Full Text] [Related]
27. [Pharmacologic prevention of cardiovascular diseases with calcium antagonists].
Rafflenbeul W
Z Kardiol; 1992; 81 Suppl 4():211-20. PubMed ID: 1290301
[TBL] [Abstract][Full Text] [Related]
28. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
Just H; Frey M
Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
[TBL] [Abstract][Full Text] [Related]
29. Coronary dilation with nitrocompounds and calcium antagonists.
Jost S; Rafflenbeul W; Lichtlen PR
Z Kardiol; 1990; 79 Suppl 3():113-20. PubMed ID: 2099034
[TBL] [Abstract][Full Text] [Related]
30. The role of diltiazem in treating hypertension and coronary artery disease: new approaches to preventing first events.
Fodor JG; Boulet AP; Savard D; Nadeau C; Rakusan K; Chockalingam A; Langer A
Can J Cardiol; 1997 May; 13(5):495-503. PubMed ID: 9179089
[TBL] [Abstract][Full Text] [Related]
31. [The ischemic heart--causes, effects and therapy].
Tillmanns H
Klin Anasthesiol Intensivther; 1995; 47():206-20. PubMed ID: 7715175
[No Abstract] [Full Text] [Related]
32. [Silent myocardial ischemia and nitrates].
Palma Gámiz JL
Ann Cardiol Angeiol (Paris); 1997; 46(7):431-40. PubMed ID: 9452778
[TBL] [Abstract][Full Text] [Related]
33. [Endothelin--an important factor in coronary heart disease].
Christensen G
Tidsskr Nor Laegeforen; 1994 Nov; 114(29):3450-3. PubMed ID: 7998052
[TBL] [Abstract][Full Text] [Related]
34. [Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion].
Lièvre M; Boissel JP
Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():91-8. PubMed ID: 8304818
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of myocardial ischaemia and the prevention of necrosis.
Taylor RR
Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288
[No Abstract] [Full Text] [Related]
36. No reflow phenomenon in coronary heart disease.
Ito H
J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
[TBL] [Abstract][Full Text] [Related]
37. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
Motz W; Scheler S; Strauer BE
Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
[TBL] [Abstract][Full Text] [Related]
38. [Calcium antagonists in the therapy of ischemic heart disease].
Makolkin BI; Vakhliaev VD
Klin Med (Mosk); 1994; 72(1):4-7. PubMed ID: 8196322
[No Abstract] [Full Text] [Related]
39. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
Noll G; Kaufmann U; Wenzel RR; Lüscher TF
Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
